Interactions between Dyskerin expression and known prognosis factors

Slides:



Advertisements
Similar presentations
What is he doing?.
Advertisements

Making Sense of Novel Prognostics: NOTCH1, SF3B1 Jennifer R Brown, MD PhD Director, CLL Center Dana-Farber Cancer Institute October 24, 2014.
1 times table 2 times table 3 times table 4 times table 5 times table
12.4 MUTATIONS I. Kinds of Mutations
Supplementary Material Epigenetic histone modifications of human transposable elements: genome defense versus exaptation Ahsan Huda, Leonardo Mariño-Ramírez.
Things to Remember about HIV Anyone can get HIV: young or old, woman or man, gay or straight.
Multivariate Descriptive Research In the previous lecture, we discussed ways to quantify the relationship between two variables when those variables are.
GeneSequenceTa °CFunction IDH1 exon 4 Fw5'-AGCTCTATATGCCATCACTGC-3' 62 Methylation Rv 5 ’ -AACATGCAAAATCACATTATTGCC-3 ’ IDH2 exon 4 Fw 5 ’ -AATTTTAGGACCCCCGTCTG-3.
PatientVPA final dose (mg/kg/day) VPA final serum level (mM)(mg/L) Supplemental.
Jeopardy Hypothesis Testing t-test Basics t for Indep. Samples Related Samples t— Didn’t cover— Skip for now Ancient History $100 $200$200 $300 $500 $400.
Multivariate Descriptive Research In the previous lecture, we discussed ways to quantify the relationship between two variables when those variables are.
Karyotype Notes. A karyotype is a “ picture ” of a person ’ s chromosomes. Each person has 46 chromosomes, in 23 pairs. Pairs 1-22 are called Autosomes.
$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.
Tables Learning Support
第 8 章 PowerPoint 2003 的使用 1 PowerPoint 2003 窗口简介 2 PowerPoint 2003 演示文稿的创建与放映 3 幻灯片的基本操作.
Supplementary Figure 1: Correlation analysis of DKC1 mRNA and dyskerin protein quantity in neuroblastoma cell lines.
Primers to map bsd deletion points on genomic DNA NameForwardReverse Amplicon size (base pairs) A15’-CCACGGATGGAGTGAGTTCT-3’5’-GCCCCCAAGATGAGGATTAT-3’931.
Gender equality Adam Ondroušek 3. B. Outline Why? What is gender equality? Law aspects Economic aspects Organizations who fight against differences between.
Evaluate the expression for the given value 1.9 b+7 when b=14 A. 189 B. 63 C. 18 D. 133.
Geisler C et al. Proc ASH 2011;Abstract 290.
The chronic lymphoid leukaemias
Table 1. Patient Characteristics
  TUMOR PD-L1 TIL PD-L1 TUMOR & TIL PD-L1 Age Low High P value R Pearson
Karyotypes Objective: Learn and Identify characteristics of Karyotypes
Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.
Human Genetics part 2.
Times Tables.
HIV surveillance in Northern Ireland 2014
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia by Marco Herling, Kaushali.
مبررات إدخال الحاسوب في رياض الأطفال
Fig. S1 PIPKI is highly expressed in cancer cell lines
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Preview Chapter 12 Multiple Choice Short Response Extended Response
Karyotyping.
Early studies evaluating role of immune infiltrate in colorectal cancer
EVALUATE EFFECTIVENESS OF GEFIITINIB IN FIRST LINE TREATIMENT AVANCED NSCLC PATIENTS WITH EGFR MUTATION BS TRẦN THỊ CHUNG, Ths. NGUYỄN THỊ OANH Oncology.
Figure 2 The association between CD8+ T‑cell density of the tumour
A Effect of GO on survival stratified by CD33 expression on CD34+ blasts B Effect of GO dose on survival stratified by CD33 expression on CD34+ blasts.
Supplementary Data Tables, Community Health Indicators
What is the best frontline regimen for CLL patients
وضعیت موجود مرگ و میر و علل مرگ غیر مادری در افراد سال کارشناس اداره سلامت میانسالان معصومه آرشین چی همدان 27 و 28 تیرماه 1396.
Table 2. Progression-Free Survival
21twelveinteractive.com/ twitter.com/21twelveI/ facebook.com/21twelveinteractive/ linkedin.com/company/21twelve-interactive/ pinterest.com/21twelveinteractive/
Figure 3 Age, pretreatment, sex, and leukopenia do not influence CD19+ cell repopulation Age, pretreatment, sex, and leukopenia do not influence CD19+
Table S1. Inverse correlation between FOXC2 and PP2A/C expression (tested by one-tailed Spearman's nonparametric correlation test, correlation coefficient.
A New Therapeutic Target for Leukemia Comes to the Surface
Visualization of a global auxin‐response gradient in the root meristem
Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis  Anna Ermarth, Matthew Bryce,
What are they?? How do we use them?
Bellringer Please add questions (2 per page) and a summary to your Blood Types and Sex-Linked Notes. Summary 3 things you learned 2 things you found interesting.
Categorizing cell type‐specific auxin responses.
Averages: Mean from a Frequency Table
Warm Up Complete Edpuzzle on pedigrees
Supplementary Table 1. Summary of surface marker expression of adherent (A) and sphere-forming MRT cell lines (B), and primary tumors (C). A Sample CD146.
3 times tables.
6 times tables.
Supplementary Table S2 Correlation between pre-operative plasma miR-451 or miR-486 concentrations and clinicopathologic features in gastric cancer patients.
What are they?? How do we use them?
Interaction between reboxetine and ADRA2B genotype influences post-treatment symptoms of irritability, anxiety, and dizziness. Interaction between reboxetine.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Fig. 1. Kaplan-Meier curves for PFS and OS
European Urology Oncology
Figure S1. A. B. Figure S1. Kaplan-Meier curve of progression-free survival by treatment group in soluble heregulin (HRG)-high population (A) and soluble.
Bortezomib induces an NRF2 signature and NRF2 protein in tumor cells from leukemic MCL. Gene sets regulated by bortezomib (Supplementary Tables S3 and.
Number of treatments ____________________________________________
Global mutational landscape of the 170 lung adenocarcinoma patients (discovery cohort). Global mutational landscape of the 170 lung adenocarcinoma patients.
Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across.
Immunohistochemical determination of TIM-3 expression in ccRCC.
median of follow-up (month)
* OS >3yr with No Next Line * * * * *
Presentation transcript:

Interactions between Dyskerin expression and known prognosis factors PFS cox p value p value OS cox p value OS after treatment cox p value   average Dyskerin expression correlation with Dyskerin (student's ttest p value) single factor additive with Dyskerin interactive with Dyskerin sex Man (n=67) 1.03 0.72 0.50 0.75 0.71 0.76 0.69 0.01 0.03 Woman (n=39 0.97 age <65 (n=52) 1.05 0.20 0.403 0.494 0.42 0.05 0.001 0.005 >65 (n=52) 0.89 Immunoglobulin Mutated (n=58) 1.00 0.73 0.021 0.08 0.78 0.99 0.90 0.004 0.003 Unmutated (n=44) 0.96 LCDT low (n=63) 0.91 0.36 0.54 0.59 0.86 0.25 0.23 high (n=18) 1.06 11q deletion absent (n=76) 1.02 0.06 0.79 0.92 0.04 present (n=18) 13q deletion absent (n=36) 0.60 0.34 0.82 0.87 0.02 present (n=58) 0.98 17p deletion absent (n=9) 0.11 0.006 present (n=5) 2.15 trisomy 12 absent (n=84) 0.21 0.24 0.77 0.16 present n=10) 0.88 CD38 <30% (n=66) 0.93 0.84 0.64 0.83 0.27 0.37 0.48 >30% (n=28) Supplementary Table 2 Interactions between Dyskerin expression and known prognosis factors